Development of an automated immunoassay for NT-proBNP on the Dade Behring Dimension® clinical chemistry system

被引:0
|
作者
Wei, T [1 ]
Tuhy, P [1 ]
Bantum, L [1 ]
Posey, A [1 ]
Miller, L [1 ]
Singh, P [1 ]
Duffy, J [1 ]
Pierson-Perry, J [1 ]
机构
[1] Dade Behring Inc, Newark, DE USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:A13 / A14
页数:2
相关论文
共 50 条
  • [21] Evaluation of a New NT-proBNP Immunoassay on an Automated Core Laboratory System
    Logan, Samantha
    Di Meo, Ashley
    Shapero, Stacey
    Fabros, Anselmo
    Taher, Jennifer
    Kulasingam, Vathany
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2024, 9 (03): : 579 - 585
  • [22] Performance of an automated low density lipoprotein (ALDL) method on the Dade Behring Dimension® clinical chemistry system.
    Gorzynski, TJ
    Prusisz, R
    Jurga, R
    Jones, H
    Bacal, D
    Garvey, K
    Christenson, R
    CLINICAL CHEMISTRY, 2002, 48 (06) : A108 - A108
  • [23] Analytical and clinical performance of NT-proBNP immunoassay
    Prontera, C
    Ripoli, A
    Zucchelli, GC
    Emdin, M
    Iervasi, A
    Passino, C
    Mercuri, A
    Turchi, S
    Clerico, A
    EUROMEDLAB 2003: PROCEEDINGS OF THE 15TH IFCC-FESCC EUROPEAN CONGRESS OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, : 807 - 810
  • [24] Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform
    Hammerer-Lercher, Angelika
    Griesmacher, Andrea
    Poelzl, Gerhard
    Brinskelle-Schmal, Natascha
    Mair, Johannes
    Frick, Matthias
    Hawa, Gerhard
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (10) : 1305 - 1308
  • [25] Performance of a PSA assay for the Dade Behring Dimension® RxL clinical chemistry system.
    Zhao, W
    Demers, L
    Walsh, P
    Fisher, G
    CLINICAL CHEMISTRY, 1998, 44 : A24 - A24
  • [26] Clinical evaluation of the Dade Behring Total PSA assay on the Dimension® clinical chemistry system.
    Jurga, PA
    Mandichak, J
    Ackermann, H
    Rivera, D
    Pernyeszi, M
    Loebel, J
    Thiel, R
    CLINICAL CHEMISTRY, 2002, 48 (06) : A144 - A144
  • [27] Performance of an HCG assay for the Dade Behring Dimension® RxL clinical chemistry system.
    Rossi, R
    Demers, L
    Walsh, P
    Fisher, G
    CLINICAL CHEMISTRY, 1998, 44 : A152 - A152
  • [28] Performance of a revised glucose method on the Dade Behring Dimension® clinical chemistry system.
    Amsel, L
    Crawford, S
    Cybulski, R
    CLINICAL CHEMISTRY, 2003, 49 (06) : A74 - A74
  • [29] Performance of the mycophenolic acid method on the Dade Behring Dimension® clinical chemistry system.
    Goss, S. P.
    Driscoll, J. A.
    McClafferty, T. A.
    Edwards, R. L.
    Chun, A.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A63 - A63
  • [30] Performance of the valproic acid method on the Dade Behring Dimension® clinical chemistry system.
    Kilgore, D
    LeCompte, S
    Chu, V
    Garvey, K
    Gorzynski, T
    CLINICAL CHEMISTRY, 1999, 45 (06) : A127 - A127